The IL13α 2R paves the way for anti-glioma nanotherapy

Glioblastoma (GBM) is one of the most aggressive (grade IV) gliomas characterized by a high rate of recurrence, resistance to therapy and a grim survival prognosis. The long-awaited improvement in GBM patients’ survival rates essentially depends on advances in the development of new therapeutic appr...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Ilya V. Ulasov, Anton Borovjagin, Anastasia Laevskaya, Margarita Kamynina, Peter Timashev, Laura Cerchia, Elena A. Rozhkova
Format:	Artigo
Sprog:	Inglês
Udgivet:	KeAi Communications Co., Ltd. 2023-01-01
Serier:	Genes and Diseases
Fag:	Brain tumor Experimental therapy GBM IL-13Rα2 Nanoparticles Receptor
Online adgang:	http://www.sciencedirect.com/science/article/pii/S2352304221001033
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!